Friday, June 12, 2020 1:00:59 PM
The latest direct offering seems to have come a bit earlier than I was expecting and it seems likely to me this relates to alternate plans regarding the CFIUS decision.
I think there's a decent chance EksoUE can develop into an at-home product MUCH faster than an ambulatory exoskeleton feasibly can. The shift to UE makes me rethink the broader concepts too.
I'm starting to put together a theoretical case in my mind for why it might be that upper body exoskeleton function is largely more important (in terms of order of importance in a combat situation) than lower body function for soldiers.
It seems to me people's shoulders largely point their guns (the same line of sight reasons your eyes are near the top of your body) and their legs are only secondary to getting their shoulders in the right place at the right time.
I sort of imagine what was found in the last batch of exoskeleton testing is that you can reduce metabolic activities for movement and that's fine and dandy, but the second the operator goes into a combat environment and is doing a lot of upper body repositioning - perhaps the lower body stuff can't handle it with out more coordinated upper body robotic functionalization.
More broadly, it's possible even lower body rehabilitation will be shown to be more effective while simultaneously having upper extremity rehabilitation. I think gaits are really the whole body, not just the legs.
Going into UE for rehab seems it would be a good way for some insights that translate into their work making defense industry UE parts. A win-win.
I'm long EKSO
Recent EKSO News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/12/2024 08:29:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:24:07 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/30/2024 09:30:16 PM
- Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering • GlobeNewswire Inc. • 08/30/2024 02:42:42 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/28/2024 01:25:19 PM
- Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal • GlobeNewswire Inc. • 08/20/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/29/2024 09:22:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/29/2024 08:55:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 08:39:19 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 08:39:17 PM
- Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024 • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/26/2024 08:15:48 PM
- Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024 • GlobeNewswire Inc. • 07/22/2024 12:00:00 PM
- Ekso Bionics Announces Research Partnership with Shepherd Center • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors • GlobeNewswire Inc. • 06/17/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 09:28:29 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/03/2024 08:58:45 PM
- Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky • GlobeNewswire Inc. • 05/10/2024 12:00:00 PM
- Ekso Bionics Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal • GlobeNewswire Inc. • 04/12/2024 12:00:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/04/2024 09:14:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:08:54 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM